The pharmaceutical industry has now been implementing the PV Lifecycle approach for several years, with a focus on complying with the requirements, especially for CPV. This session will look at ways in which companies are beginning to leverage the lifecycle approach to identify and close gaps to improve manufacturing robustness, and to find solutions to challenges that have arisen in using the lifecycle approach.
Dave White, Associate Director, On Market Technical, Chemical Development, AstraZeneca
Sandy Hopkins, Regional Director, MS&T, AstraZeneca
Bruce Davis, Principal, BD Global Consulting
Tara Scherder, Partner, SynoloStats, LLC